These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 4039514

  • 21. Inhibition of lactation by a long-acting bromocriptine.
    Peters F, Del Pozo E, Conti A, Breckwoldt M.
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [Abstract] [Full Text] [Related]

  • 22. Lisuride in parkinsonism.
    Parkes JD, Schachter M, Marsden CD, Smith B, Wilson A.
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
    Melis GB, Mais V, Paoletti AM, Beneventi F, Gambacciani M, Fioretti P.
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):311-4. PubMed ID: 3279351
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative study of the effects of lisuride and pimozide on the preovulatory surge of FSH, LH and prolactin in rat.
    Kun I, Simionescu L, Oprescu M, Zamfir-Grigorescu D.
    Endocrinologie; 1984 Mar; 22(3):177-82. PubMed ID: 6436960
    [Abstract] [Full Text] [Related]

  • 28. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C, Leke R.
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
    Abate F, Oliva A, Baviera G, La Spada R, Leonardi R, Bellinvia G.
    Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Antilactogenic activity of methergoline. Blocking of lactation and inhibition of prolactin secretion in the postpartum period].
    Delitala G, Lodico G, Stoppelli I.
    Minerva Ginecol; 1977 May; 29(5):359-68. PubMed ID: 896082
    [No Abstract] [Full Text] [Related]

  • 37. Terguride in the treatment of hyperprolactinemia.
    Vĕtr M, Talas M, Pohanka J, Gazárek F, Fingerová H.
    Acta Univ Palacki Olomuc Fac Med; 1990 May; 125():155-60. PubMed ID: 2150271
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Puerperal inhibition of lactation with metergoline or bromocriptine].
    Fischer T, Streitmatter A, Gerede A, Frauendorf A, Krause M, Feige A.
    Z Geburtshilfe Neonatol; 1995 May; 199(3):111-5. PubMed ID: 7553254
    [Abstract] [Full Text] [Related]

  • 40. [Evaluation of the clinical effect of lisuride hydrogen maleate (SH-1072) on benign prostatic hypertrophy: on the clinical results and mechanism of action].
    Okada K, Yamauchi T, Oishi K, Hashimura T, Kawamura J, Yoshida O.
    Hinyokika Kiyo; 1985 May; 31(5):885-93. PubMed ID: 2413748
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.